## 

## 

## 

## 

|||||||Page|
|---|---|---|---|---|---|---|
|Trustees'|annual<br>report (incorporating||the|director's|report)|1-3|
|Independent<br>examiner's<br>report||to the|trustees||||
|Statement<br>account)|offinancial<br>activities|(including||income and expenditure|||
|Statement|offinancial<br>position||||||
|Statement|ofcash flows||||||
|Notes to the financial<br>statements||||||8-14|





# 

## 

## 

## 

|Registered|charity name|charity name|Cancer Aid ForNorth/East|Cancer Aid ForNorth/East|(Sri Lanka)|
|---|---|---|---|---|---|
|Charity registration||number|1044299|||
|Company|registration|number|02871824|||
|Principal|office and registered||C206 Cunningham|House||
|office|||19-21Westfield Lane|||
||||Harrow|||
||||Middlesex|||
||||HA3 9ED|||



## 

|Dr JNamasivayam||
|---|---|
|Dr KArunasalam||
|Mr K Balendran||
|Mr V Sivasundram||
|Mr M Thangarajah||
|Mr K Tharmakulasingam|(Resigned on 11April 2021)|
|Dr P Thayalasekaran||
|Mr M Sri Ragavan||
|Dr.G. Wijayasingam||
|Mrs SThayalasekaran||
|Miss D Baleswaran||
|Miss RBaleswaran||
|Miss J Rajan||
|Mrs RVaheesan||





# 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



# 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

|||||2020||2019|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|||
||||funds|funds|Total funds|Total funds|
|||Note|||||
|Income and endowments|||||||
|Donations<br>and legacies<br>Charitable<br>activities<br>Other trading activities<br>Investment<br>income||5<br>6<br>7<br>8|34,962<br>5,852<br>734<br>166||34,962<br>5,852<br>734<br>166|20,783<br>5,122<br>14,525<br>293|
|Total income|||41,714||41,714|40,723|
|Expenditure|||||||
|Expenditure<br>on raising funds:|||||||
|Costs ofother trading <br>Expenditure<br>on charitable<br>Other expenditure|activities<br>activities|9<br>10,11<br>13|52,307<br>250||52,307<br>250|6,347<br>39,878|
|Total expenditure|||52,557||52,557|46,225|
|Net expenditure<br>and net|movement|in|||||
|funds|||(10,843)||(10,843)|(5,502)|
|Reconciliation offunds|||||||
|Total funds brought forward|||94,064|1,405|95,469|100,971|
|Total funds carried forward|||83,221|1,405|84,626|95,469|





## 

## 

## 

|||30November|2020||||
|---|---|---|---|---|---|---|
|||||2020||2019|
|||Note|||||
|Current assets|||||||
|Debtors<br>Cash at bank and in hand|||17|11,148<br>73,851||5,917<br>94,175|
|||||84,999||100,092|
|Creditors: amounts|falling due within|one year|18|373||4,623|
|Net current assets|||||84,626|95,469|
|Total assets less current liabilities|||||84,626|95,469|
|Net assets|||||84,626|95,469|
|Funds ofthe charity|||||||
|Restricted<br>funds<br>Unrestricted<br>funds|||||1,405<br>83,221|1,405<br>94,064|
|Total charity funds|||19||84,626|95,469|





## 

## 

## 

## 

||Year end|ed 30 November<br>2|020||
|---|---|---|---|---|
||||2020|2019|
|Cash flows from operating|activities||||
|Net expenditure|||(10,843)|(5,502)|
|Adjustments for:|||||
|Other interest receivable<br>and similar income<br>Interest payable<br>and similar charges<br>Accrued (income)/expenses|||(166)<br>13<br>(4,250)|(293)<br>4,160|
|Changes in:|||||
|Trade and other debtors|||(5,231)|3,185|
|Cash generated<br>from operations|||(20,477)|1,550|
|Interest paid<br>Interest received|||(13)<br>166|293|
|Net cash (used in)/from<br>operating<br>activities|||(20,324)|1,843|
|Net (decrease)/increase<br>in <br>Cash and cash equivalents|cash and cash <br>at beginning|equivalents<br>ofyear|(20&324)<br>94,175|1,843<br>92,332|
|Cash and cash equivalents|at end ofyear||73,851|94,175|





# 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



# 

## 

## 

## 

## 

## 

## 

## 

## 

|each direct<br>|or/trus|tee<br>amounts to|f5.00each.|||p||y|
|---|---|---|---|---|---|---|---|---|
|Donations|and|legacies|||||||
||||Unrestricted|Total|Funds|Unrestricted|Total|Funds|
||||Funds||2020|Funds||2019|
|Donations|||||||||
|-General<br>-Regular<br>Subscriptions|||17,124<br>6,501||17,124<br>6,501|4,717<br>5,916||4,717<br>5,916|
|-Members|||11,337||11,337|10,150||10,150|
||||34,962||34,962|20,783||20,783|





## 

## 

## 

## 

## 

|6.|Charitable|activities||||||
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||||Funds|2020|Funds|2019|
||||||||6|
||Tax rebate|on gift aid donations||5,852|5,852|5,122|5,122|
|7.|Other trading activities|||||||
|||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||||Funds|2020|Funds|2019|
||Fundraising|event- Dinner|Dance|||13,203|13,203|
||Till collection|||734|734|512|512|
||Fundraising|event-cultural|show|||810|810|
|||||734|734|14,525|14,525|
|8.|Investment|income||||||
|||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||||Funds|2020|Funds|2019|
||Bank interest receivable|||166|166|272|272|
||Other interest receivable|||||21|21|
|||||166|166|293|293|
|9.|Costs ofother trading activities|||||||
|||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||||Funds|2020|Funds|2019|
|||||f||||
||Fundraising|event- Dinner|Dance|||6,347|6,347|





## 

## 

## 

## 

## 

|Expenditure<br>on ch|aritable||activ|ities<br>by fund ty|pe|||
|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|Total Funds|
||||||Funds|Funds|2020|
|CANE-Jaffna-running<br>cost<br>CANE-Jaffna-refurbisment<br>cost<br>Batticaloa Sri Lanka Cancer Society<br>Personal protective<br>equipment<br>to Sri Lanka<br>Support costs|||||15,005<br>31,541<br>1,400<br>3,436<br>925||15,005<br>31,541<br>1,400<br>3,436<br>925|
||||||52,307||52,307|
||||||Unrestrtcted|Restricted|Total Funds|
||||||Funds|Funds|2019|
|CANE-Jaffna-running<br>cost<br>Batticaloa Sri Lanka Cancer Society<br>Awareness<br>and medical screening<br>programme|||||26,723<br>1,400|6,784|26,723<br>1,400<br>6,784|
|Support costs|||||4,971||4,971|
||||||33,094|6,784|39,878|



## 

|||||||Activities|||||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||undertaken|||Total funds|Total fund|
|||||||directly|Support|costs|2020|2019|
|CANE-Jaffna-running|||cost|||15,005|||15,005|31,040|
|CANE-Jaffna-refurbisment<br>Batticaloa Sri Lanka Cancer||||cost<br> Society||31,541<br>1,400|||31,541<br>1,400|1,400|
|Awareness|and medical screening||||||||||
|programme<br>Personal protective||equipment|||to Sri|||||6,784|
|Lanka||||||3,436|||3,436||
|Governance|costs|||||||925|925|654|
|||||||51,382||925|52,307|39,878|
|12. Analysis ofsupport|||costs||||||||
||||||||||2020|2019|
|Support costs|||||||||||
|Subcontract||||||||||4,160|
|Printing,<br>postage|and stationery|||||||||157|
|||||||||||4,317|





## 

## 

## 

## 

## 

## 

|12. Analysis of|support cos|ts (corri»rwd)||||
|---|---|---|---|---|---|
|||||2020|2019|
|Governance<br>costs||||||
|Miscellaneous|||||19|
|Accountancy<br>and|independent|examination|fees|360|450|
|Costs oftrustees'|meetings||||51|
|Website cost||||517|86|
|Companies<br>House|filing fee|||13|13|
|Subscription-Data|protection|||35|35|
|||||925|654|



## 

||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|---|---|---|---|---|---|---|---|---|
||||||Funds|2020|Funds|2019|
||Donation||||250|250|||
|14.|Independent|examination|fees||||||
||||||||2020|2019|
||Fees payable|to the independent||examiner|for:||||
||Independent|examination|ofthe|financial|statements||150|200|



## 

## 

## 

|17.|received by the truste<br> Debtors|es.||||
|---|---|---|---|---|---|
|||||2020|2019|
||Trade debtors||||620|
||Other debtors|||11,148|5,297|
|||||11,148|5,917|
|18.|Creditors: amounts|falling due within|one year|||
|||||2020|2019|
||Accruals and deferred|income||373|4,623|





## 

## 

## 

|Analysis ofc|Analysis ofc|haritable<br>funds||||||
|---|---|---|---|---|---|---|---|
|Unrestricted||funds||||||
|||||At|||At|
||||I December|||30|November|
|||||2019|Income|Expenditure|2020|
|General funds||||94,064|41,714|(52,557)|83,221|
|||||At|||At|
||||I|December||30|November|
|||||2018|Income|Expenditure|2019|
|General funds||||92,782|40,723|(39,441)|94,064|
|Restricted|funds|||||||
|||||At|||At|
||||I|December||30|November|
|||||2019|Income|Expenditure|2020|
|Awareness|and|medical screening||||||
|programme||||1,405|||1,405|
|||||1,405|||1,405|
|||||At|||At|
||||I December|||30November||
|||||2018|Income|Expenditure|2019|
|Awareness|and|medical screening||||||
|programme/Run||to beat cancer||8,189||(6,784)|1,405|
|||||8,189||(6,784)|1,405|





## 

## 

## 

## 

|||||Unrestricted|Restricted|Total Funds|
|---|---|---|---|---|---|---|
|||||Funds|Funds|2020|
||||||f||
||Current assets<br>Creditors<br>less than||1 year|83,594<br>(373)|1,405|84,999<br>(373)|
||Net assets|||83,221|1,405|84,626|
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2019|
||Current assets|||98,687|1,405|100,092|
||Creditors|less than|1 year|(4,623)||(4,623)|
||Net assets|||94,064|1,405|95,469|
|21.|Analysis ofchanges in net debt||||||
|||||At||At|
|||||1 Dec 2019|Cash flows|30Nov 2020|
|||||||K|
||Cash at bank and in||hand|94,175|(20,324)|73,S51|



